Pharmacy News

September 13, 2019

• KRS Global Biotechnology, Inc. Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility

September 10, 2019

• The Metrix Company of Dubuque, Iowa is Recalling Specific Lots of the Empty IV Flexible Containers (Bag) Marketed Under the Metrix Secure EVA Dual Chamber and Baxter ExactaMix Names, Due to the Potential for Leaking of the IV Bag at the Chamber Divider Rod

September 9, 2019

• Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension 2400 mg/30 mL due to Microbial Contamination

September 6, 2019

• Hospira, Inc., Issues A Voluntary Nationwide Recall for one lot of BACTERIOSTATIC WATER for Injection, USP, due to a Potential Lack of Sterility Assurance

August 27, 2018

• FDA requests recall of sterile compounded drug products produced by Pacifico National Inc., dba AmEx Pharmacy, reminds patients and health care professionals to stop using due to potential risks

August 22, 2019

• Anticonvulsant Recalled

August 22, 2019

• Antiplatelet Agent Recalled

August 22, 2019

• Edwards Lifesciences, LLC, Recalls SAPIEN 3 Ultra Delivery System Due to Burst Balloons During Surgery, Which May Result in Vascular Injury, Bleeding, or Surgical Intervention

August 15, 2019

• Pfizer Inc. Issues a Voluntary Nationwide Recall for 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products

August 12, 2019

• Fresenius Kabi Recalls Volumat MC Agilia Infusion Pump and Vigilant Agilia Drug Library Due to a “Low Priority” “Keep Vein Open (KVO), End of Infusion” Alarm and Multiple Software Errors

August 12, 2019

• Vivitrol DS 380mg Suspension Kit Recall

August 9, 2019

• Antibiotic Tablets Recalled

August 9, 2019

• Oral Contraceptive Recalled

August 8, 2019

• Ridge Properties LLC DBA Pain Relief Naturally Issues Voluntary Nationwide Recall of PRE-TAT

August 5, 2019

• Abbott (Formerly St. Jude Medical Inc.), Recalls Ellipse Implantable Cardioverter Defibrillators Due to Exposed Aluminum Wires That May Prevent Defibrillation Therapy

August 2, 2019

• Centurion Medical Products Recalls Airway Kit containing Sheridan® Endotracheal Tubes Due to Potential for the Tube Connector to Dislodge, Which May Result in Disconnection of the Patient from the Breathing Circuit

August 2, 2019

• QIAGEN Recalls Filter Tips for use with the QIAsymphony SP/AS Instruments Due to Potential to Leak, Which May Result in Delayed or Inaccurate Results

August 1, 2019

• Chemotherapy Tablets Recalled

August 1, 2019

• Blood Pressure Pills Pulled

August 1, 2019

• Over 135,000 Containers of Fluid Injection Recalled

July 25, 2019

• Over 330,000 Bags of Heart Failure Treatment Recalled

July 23, 2019

• Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results

July 23, 2019

• Datascope/Getinge Recalls Cardiosave Hybrid, Cardiosave Rescue, CS300 and CS100/100i Intra-Aortic Balloon Pumps (IABP) Due to Potential Battery Failure

July 19, 2019

• Bayer Statement on Voluntary Recall of Two Lots of Kogenate® FS Antihemophilic Factor (Recombinant) in the United States

July 18, 2019

• Becton Dickinson (BD) Recalls Alaris Infusion Sets for the Alaris Pump Model 8100 Due to Potential for Tube Collapse that May Cause Unintended Delivery or Faster than Expected Delivery of Medication

July 17, 2019

• Teleflex Recalls NEONATAL ConchaSmart Breathing Circuit Due to Circuit Cracks

July 11, 2019

• Gamunex-C 10% Consumer Level Withdrawal

July 10, 2019

• Altaire Pharmaceuticals, Inc. Voluntary Recall of Multiple Ophthalmic Products Sold at CVS

July 5, 2019

• Parkinson Disease Drug Pulled

July 5, 2019

• Sedative Injection Recalled

July 5, 2019

• lSurgical Injection Recalled

July 3, 2018

• Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products Sold at Walgreens

July 3, 2019

• Altaire Pharmaceuticals, Inc. Issues Voluntary Recall of Multiple Ophthalmic Products

July 3, 2019

• Voluntary Nationwide Recall of Two Lots of Fluorouracil Injection

July 1, 2019

• Safety Communication for Certain Medtronic MiniMed Insulin Pumps

July 1, 2019

• SmartSite Syringe Administration Set Recall

June 28, 2019

• Gamunex-C 10% Consumer Level Withdrawal

June 27, 2018

• Cetirizine Oral Solution Recalled

June 27, 2018

• Breast Cancer Drug Recalled

June 27, 2018

• enFlow Fluid Warming System Disposable Cartridge Recall

June 25, 2019

• Losartan Potassium and Losartan HCTZ Recall

June 20, 2019

• Heparin Sodium in Dextrose Recall

June 20, 2019

• Zyflo CR Recall

June 20, 2019

• Pecgen DMX Cough Suppressant Expectorant (Class I) Recall

May 29, 2019

• CVS Brand Meds Recalled

May 29, 2019

• Recall Active for Promacta

May 29, 2019

• Over 170,000 Bottles of Prescription Laxative Recalled

May 23, 2019

• Additional Recalls issued for Losartan Potassium Tablets

May 11, 2019

• Novartis Issues Voluntary Nationwide Recall of Promacta

May 9, 2019

• Four Firms Issue New Recalls for Losartan

May 9, 2019

• Diabetes Drug Recalled

May 9, 2019

• Class II Recall Active for Hydromorphone

May 9, 2019

• Recall Active for Bevacizumab

April 4, 2019

• FDA Recalls Fayosim Tablets

April 4, 2019

• Class II Recall Active for Combigan

March 30, 2019

• Kingston Pharma recalls Nautrals baby cough syrup plus mucus

March 30, 2019

• Hypertension Drug Recalled

March 30, 2019

• Antibiotic Eye Drops Recalled

March 4, 2019

• FDA Issues Safety Alert for JAK Inhibitor

March 4, 2019

• Apotex Corp Issues Voluntary Recall of Drospirenone and Ethinyl Estradiol Tablets

March 1, 2019

• Aurobindo Pharmaceuticals Limited Issues Valsartan Amlodipine Tablets Recall

February 28, 2019

• Camber Pharmaceuticals Limited Issues Losartan Potassium Recall

February 22, 2019

• Macleods Pharmaceuticals Limited Issues Losartan Potassium/HCT Recall

February 8, 2019

• Antibiotic Recalled

February 8, 2019

• Hypertension Drug Recalled

February 8, 2019

• Antihistamine Pulled

February 8, 2019

• Blood Pressure-Water Pill Recalled

February 4, 2019

• Medex Cardio Pulmonary recalls Sterile Saline and Sterile Water

February 3, 2019

• Blood Thinner Recalled

February 2, 2019

• Topical Steroid Recalled

February 2, 2019

• Cholesterol Drug Recalled

February 1, 2019

• Terrific Care LLC Medex Supply Recalls CoaguCheck XS Test Strips

January 18, 2019

• Surgical Muscle Relaxant Pulled in Class I Recall

January 18, 2019

• Oral Suspension Antibiotic Recalled

January 18, 2019

• Intravitreal Corticosteroid Implant Recalled

January 18, 2019

• Class I Recall of Antibiotic Injection

January 1, 2019

• New Opioid Prescription Safety Measures

December 7, 2018

• Acne Cream Recalled Over Impurities

December 7, 2018

• Antipsychotic Drug Recalled

December 7, 2018

• Anemia Injection Recalled

December 7, 2018

• FDA alerts health care professionals and patients not to use drug products intended to be sterile from Promise Pharmacy

December 5, 2018

• Infant Ibuprofen Recalled

December 4, 2018

• Mylan expands Voluntary Recall of Valsartan

December 4, 2018

• Blood Thinner Pulled

November 30, 2018

• Chewable Antacids Recalled

November 30, 2018

• Mylan to Recall All Batches of Blood Pressure Medicine Valsartan in US

November 8, 2018

• Nationwide Recall of Losartan

November 8, 2018

• Opioid Solution recalled

November 8, 2018

• Analgesic Solution Recalled

November 8, 2018

• Hypertension Drug Recalled

November 2, 2018

• Epi-Pen Alert

November 2, 2018

• Diuretic Recalled

November 2, 2018

• Antibiotic Injection Recalled

November 2, 2018

• Skin Solution Recalled

November 2, 2018

• Intravenous Antiviral Recalled

November 2, 2018

• Beta Blocker Pulled

October 12, 2018

• Class l Recall for Muscle Relaxant

October 12, 2018

• Steroid-Antifungal Cream Recalled

October 12, 2018

• Biopharmaceutical Recalled

October 12, 2018

• Antipsychotic Pulled

September 27, 2018

• Muscle Relaxant Pulled After Diabetes Drug Found.

September 27, 2018

• Over 15,000 Bottles of Anticonvulsant Recalled.

August 24, 2018

• Contaminant Prompts Recall of Ace Inhibitor

August 24, 2018

• Chemotherapy Drug Recalled

August 24, 2018

• Recall of Blood Pressure Drug Expands

August 23, 2018

• Updated additional lots added-Torrent Pharmaceuticals

August 10, 2018

• Antibiotic Tablets Recalled

August 10, 2018

• Antibiotic Vials Recalled

August 10, 2018

• NSAID Capsules Pulled

August 9, 2018

• Camber Pharmaceuticals-Valsartan Recall

August 9, 2018

• Levothyroxine and Liothyronine Recall

July 31, 2018

• AuroMedicas Piperacillin/Tazobactam Injection Recall

July 27, 2018

• Antibiotic Recall

July 27, 2018

• Multiple Pain Killers Pulled

July 27, 2018

• Blood Pressure Med Recalled

July 27, 2018

• Epinephrine Injection Recalled

July 27, 2018

• Diabetes Tablets Recalled

July 17, 2018

• Prinston Pharmaceutical Inc Issues Voluntary Nationwide Recall of Valsartan and Valsartan HCTZ Tablets Due to Detection of a Trace Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in The Products

July 17, 2018

• Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

July 13, 2018

• Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)

May 31, 2018

• Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall – Due to the Potential Presence of Particulate Matter

June 4, 2018

• Fluticasone Propionate Nasal Spray by Apotex Corp: Recall – Due to Potential for Small Glass Particless

March 5, 2018

• Hydromorphone HCL Injection USP by Hospira: Recall – Potential For Empty Or Cracked Glass Vials

February 16, 2018

• Two Injectable Drugs Recalled

February 16, 2018

• Class I Recall: Injectable Antibiotic

February 13, 2018

• Acyclovir 400mg Tablets by Apace Packaging: Recall – Product Mix-up

February 7, 2018

• COPD Inhaler Capsules Recalled

February 1, 2018

• Expansive Ibuprofen Recall

February 1, 2018

• Class II Statin Recall

February 1, 2018

• Cancer Drug Recalled

January 26, 2018

• Chemotherapy Drug Recalled

January 26, 2018

• Antiseizure Tablets Recalled

January 26, 2018

• Statin Recalled

January 19, 2018

• Dozens of Compounded Preparations Recalled

January 19, 2018

• Hypertension Drug Recalled

January 16, 2018

• Safety Alert: Varubi (rolapitant) Injectable Emulsion: Health Care Provider Letter – Anaphylaxis and Other Serious Hypersensitivity Reactions

January 12, 2018

• Safety Alert: Becton-Dickinson (BD) Syringes Used to Store Compounded or Repackaged Drugs: FDA Alert – Problematic Rubber Stoppers Replaced

January 12, 2018

• Prefilled Injections Shipped with Wrong Drug

January 12, 2018

• Class I Recall: Prescription Diarrhea Med

January 12, 2018

• Recall: Depression Drug

January 10, 2018

• Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall – Product Mislabeling

January 5, 2018

• Compounded Injectable Drugs Recalled

December 28, 2017

• Class I and II Recall Active for Prescription Med

December 28, 2017

• Class I Antibiotic Recall

December 28, 2017

• Class I Recall Issued for Anxiety Med

December 22, 2017

• Diabetes Med Recalled

December 15, 2017

• Class I Recall Issued for Antidepressants Labelled as Statins

December 8, 2017

• Depression Med Bottles May Contain Antipsychotic

December 8, 2017

• Prescription Schizophrenia Med Recalled

December 1, 2017

• Inhaled Vasodilator Recalled

December 1, 2017

• Depression Treatment Recalled

November 27, 2017

• Riomet (Metformin Hydrochloride Oral Solution): Recall – Microbial Contamination

November 17, 2017

• Antiseptic Swabsticks Recalled

November 17, 2017

• Skeletal Muscle Relaxant Recalledg

November 17, 2017

• Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall – Possible Sub Potent and Super Potent Tablets

November 10, 2017

• Over 140,000 Bottles Recalled of Prostate Drug

November 3, 2017

• Multiple Pain Meds Recalled

November 3, 2017

• Compounded Injection Recalled

November 2, 2017

• Arrhythmia Drug Recalled.

October 27, 2017

• Injectable Corticosteroid Recalled.

October 27, 2017

• High Blood Pressure Med Recalled.

October 10, 2017

• Prescription NSAID Recalled.

September 22, 2017

• Recall Active for Serotonin Reuptake Inhibitor.

September 21, 2017

• Prescription Cancer Treatment Recalled.

September 19, 2017

• Nationwide Eye Drops Recall.

September 18, 2017

• Patient Death Prompts Recall.

September 8, 2017

• Prescription Antibiotic Recalled – Morton Grove Pharmaceuticals Inc. is recalling 7332 bottles of amoxicillin and clavulanate potassium for oral suspension, USP, 250/62.5 mg per 5 mL, 100 mL when reconstituted (NDC 60432-065-00).

September 7, 2017

• Nationwide Opioid Recall – The possibility of leaky containers has prompted Tris Pharma Inc. to voluntarily recall morphine sulfate oral solution, 100 mg/5 mL (20 mg/mL) (NDC 27808-082-01).

August 15, 2017

• Seizure Medication Recalled – A labeling mix-up has prompted Precision Dose Inc. to voluntarily recall carbamazepine oral suspension, USP, 100 mg/5 mL, 5-mL unit dose cups (NDC 68094-301-59).

August 15, 2017

• Antibiotic Recall Active – Sterility concerns have prompted SCA Pharmaceuticals to recall cefazolin 3 g added to 100 mL 0.9% sodium chloride, total approximate volume 115 mL, single-dose container bags (NDC 70004-0524-32).

August 9, 2017

• International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A.

August 9, 2017

• SCA Pharmaceuticals is recalling hydromorphone 0.5 mg/mL in 0.9% sodium chloride 1-mL fill in 3-mL Becton Dickinson syringe (NDC 70004-0302-05), due to lack of assurance of sterility; product has the potential to leak.

July 28, 2017

• Cyclobenzaprine HCl and Amantadine HCl by Apace Packaging: Recall – Potential Mislabeling

June 15, 2017

• Teva Pharmaceuticals, USA Extends Voluntary Nationwide Recall to Consumer/User Level for One Lot of Paliperidone Extended-Release Tablets, 3mg, 90 Count Bottles Distributed Under the Actavis Pharma Inc. Label Due to Dissolution Test Failure

June 14, 2017

• Topical Products by Phillips Company: Recall – Due to Concerns of Manufacturing Practices

June 10, 2017

• Bristol-Myers Squibb Voluntarily Recalls One Lot of Eliquis (apixaban) 5 mg Tablets

May 26, 2017

• Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 – Due to Report of Another Medicine in One Bottle

May 25, 2017

• Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas™ 24 Fe (Norethindrone Acetate and EthinylEstradiol 1mg/0.02mg Chewable Tablets and Ferrous Fumarate 75 mg) Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information

April 21, 2017

• Phenobarbital 15 mg Tablets, USP by C.O. Truxton: Recall – Labeling Error on Declared Strength

April 4, 2017

• GSK recalling nearly 600,000 Ventolin inhalers in U.S.

March 31, 2017

• FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

January 18, 2017

• Injectionn for Infants Recalled: 10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx only

January 17, 2017

• Gastrointestinal Stimulant Recalled: Tri-Coast Pharmacy, Dexpanthenol 250 mg/mL (30 ML)

January 13, 2017

• Soluble Vitamin Recalled: Tri-Coast Pharmacy, Ascorbic Acid 500 mg/mL (50 ML)

January 13, 2017

• Prostaglandin Recalled: Alprostadil 20 mcg/mL Injectable vials. The ongoing, Class II recall affects both 5-mL and 10-mL vials distributed throughout the United States

January 13, 2017

• Decongestant Recalled: Wells Pharmacy Network LLC issued a nationwide recall of nearly 2000 5-mL vials of Phenylephrine HCl Injectable, 1 mg/mL (0.1%)

January 11, 2017

• Multivitamin IV Recalled

January 9, 2017

• Antifungal Injection Recalled

January 6, 2017

• Class I Recall of Dietary Supplement

January 5, 2017

• Anti-Cancer Medication Recalled

January 4, 2017

• Class I Recall of Constipation Med.

January 2, 2017

• Paralytic Drug Recalled.

December 28, 2016

• Narcotic Injection Recalled.

December 22, 2016

• Anticoagulant Recalled: Cantrell Drug Company is recalling 1494 syringes of Heparin Sodium, 1 USP Unit/2 mL (0.5 USP Units/mL) in 0.45% Sodium Chloride.

December 16, 2016

• Erectile Dysfunction Injection Recalled: Fallon Wellness Pharmacy, LLC, is recalling 10 1-mL vials of PAPA/PHEN/PROST (papaverine/phentolamine/prostaglandin) 18 mg/0.6 mg/0.006 mg/mL Injection.

December 11, 2016

• Antiemetic Drug Recalled – India-based drug manufacturer Cadila Pharmaceuticals Limited has recalled 6 kg of its Ondansetron HCL API,

December 9, 2016

• Diabetes Medication Recalled – Ascend Laboratories LLC is recalling 1739 1000-count bottles of Metformin Hydrochloride Tablets, USP 500 mg, due to the presence of foreign tablets.

November 10, 2016

• Muscle Relaxer Recall – PharMEDium Services, LLC, initiated a nationwide recall of succinylcholine chloride, 20 mg/mL, 200 mg/10 mL, 10-mL vials

October 5, 2016

• Lansoprazole Recalled

September 28, 2016

• SSRI Recalled

September 16, 2016

• Virtus Pharmaceuticals Opco II, LLC Issues Voluntary Nationwide Recall of Hyoscyamine sulfate Due to Superpotent and Subpotent Results

September 14, 2016

• Selegiline Recalled

September 14, 2016

• ADHD Medication Recalled

September 8, 2016

• Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit

August 4, 2016

• Seizure Medication Recalled: Divalproex sodium delayed-release tablets, USP, 250 mg., failed specifications

July 28, 2016

• Acetaminophen Overdose Antidote Recalled

July 22, 2016

• 35 Lots of Antidepressant Capsules Recalled

July 16, 2016

• Oral Liquid Docusate Sodium by PharmaTech: Recall – Contaminated with B. Cepacia

May 18, 2016

• Dr. Reddy’s recalls 50,000 bottles of Ondansetron tablets in US

April 26, 2016

• Prescription Coverage to Treat Hepatitis C Update: We updated our medical necessity criteria for coverage of Hepatitis C treatment and you may now be eligible for coverage. Under our revised policy, we will no longer restrict coverage based upon fibrosis levels.

March 28, 2016

• Compounded Products by Reliable Drug Pharmacy: Recall – Potential for Mislabeling and Lack of Quality Assurance

March 21, 2016

• Recall: Sodium Bicarbonate Injection, USP by Hospira: Recall – Particulate Matter

March 9, 2016

• Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of One Lot of Amikacin Sulfate Injection USP 1 gram/4mL (250 mg/mL) Vials Due to Glass Particulate Matter

March 7, 2016

• Recall: Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall – Elevated Impurity

February 17, 2016

• Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by Pharmakon Pharmaceuticals: Recall – Super-potent Product

January 11, 2016

• Perrigo Initiates Voluntary Product Recall in the U.S. Of Children’s Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid Due to a Potential Defect with the Dosage Cup

October 30, 2015

• Sanofi US Issues Voluntary Nationwide Recall of ALL Auvi‑Q® Due to Potential Inaccurate Dosage Delivery

August 24, 2015

• Allergan Issues Voluntary Nationwide Recall In The U.S. Of Specific Lots Of REFRESH® Lacri-Lube®, REFRESH P.M. ®, FML® (fluorometholone ophthalmic ointment) 0.1%, and Blephamide® (Sulfacetamide Sodium And Prednisolone Acetate Ophthalmic Ointment, USP) 10%/0.2% For Particulate Matter

August 18, 2015

• Merck Recalls Temodar® and Temozolomide Capsules (generic) Bottles with Cracked Caps in the U.S. Due to Failure to Meet Child-Resistant Closure Requirement

August 4, 2015

• Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall – Potential Presence of Foreign Tablets Contamination

May 5, 2015

• Recall: Adrucil (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL) – Particulate Matter

April 23, 2015

• Mylan Initiates Voluntary Nationwide Recall of Select Lots of Injectable Products Due to the Presence of Particulate Matter

April 9, 2015

• Baxter Initiates Voluntary Recall of Select Lots of IV Solutions Due to the Potential Presence of Particulate Matter

November 21, 2014

• Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules

October 31, 2014

• 10 Percent Neutral Buffered Formalin by Richard-Allan Scientific: Class I Recall – May Contain Incorrect Concentration of Formalin

October 20, 2014

• Kaiser Permanente® Issues Voluntary  Recall of Venlafaxine 37.5 mg ER tablets Manufactured by Sun  Pharmaceuticals, LTD

October 22, 2014

• Assured Brand Naproxen Sodium Tablets by Contract Packaging Resources, Inc.: Recall – Packaging Mix-Up

October 3, 2014

• Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Three Lots of Ketorolac Tromethamine Injection, USP, 30mg/ml Due to Labeling the Product with the Incorrect Expiration Date

April 2014

• First Time Generics (PDF)

March 6, 2014

• Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer’s Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone’s Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules

January 17, 2013

• Advance Pharmaceutical Issues Nationwide Voluntary recall of one Lot (# 12G468) of Ferrous Sulfate Tablets, 325 mg, that may actually contain Meclizine HCl 25 mg tablets